CINDY TAHL - 01 Oct 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Signature
/s/ Cindy Tahl
Issuer symbol
FATE
Transactions as of
01 Oct 2021
Net transactions value
-$2,613,962
Form type
4
Filing time
04 Oct 2021, 16:12:16 UTC
Previous filing
27 Jan 2022
Next filing
22 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $327,500 +50,000 +46% $6.55 158,048 01 Oct 2021 Direct F1
transaction FATE Common Stock Sale $946,634 -16,312 -10% $58.03* 141,736 01 Oct 2021 Direct F1, F2
transaction FATE Common Stock Sale $1,287,966 -21,844 -15% $58.96* 119,892 01 Oct 2021 Direct F1, F3
transaction FATE Common Stock Sale $706,862 -11,844 -9.9% $59.68* 108,048 01 Oct 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -50,000 -30% $0.000000 116,643 01 Oct 2021 Common Stock 50,000 $6.55 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021.
F2 Represents the weighted average sale price of the shares sold ranging from $57.41 to $58.36 to per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 4.
F3 Represents the weighted average sale price of the shares sold ranging from $58.45 to $59.44 per share.
F4 Represents the weighted average sale price of the shares sold ranging from $59.45 to $60.07 per share.
F5 This option is fully vested.